In a career spanning 20 years of project management experience in the pharmaceutical, biotechnology, and semi-conductor industries, Mike’s primary focus since joining DPS has been on cell and gene therapy cGMP manufacturing facilities. He recently successfully executed projects for Brammer Bio’s (currently Thermo Fisher) two gene therapy / gene editing GMP manufacturing and QC operations facilities, and ElevateBio’s new state-of-the-art flexible process facility. Mike also brings a considerable background in program management, construction, and CQV on both client and A&E project teams to his current role. His know-how coupled with his extensive international experience in leading and executing global, multi-office strategic design projects up to $650M with 100+ team members, simultaneously across multiple countries, make Mike a valuable member of the DPS team.